| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 54,980 | 55,070 | 52,410 | 15,430 | 13,520 |
| Sales Growth | -0.16% | +5.08% | +239.66% | +14.13% | -33.79% |
| Net Income | -25,700 | -3,080 | 2,530 | -4,750 | 1,220 |
| Net Income Growth | -734.42% | -221.74% | +153.26% | -489.34% | -61.76% |
Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Nuvo Pharmaceuticals Inc. is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. The company's product consists of Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch. Nuvo Pharmaceuticals Inc., formerly known as Nuvo Research Inc., is headquatered in Mississauga, Ontario.
Fiscal Year End Date: 12/31